Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RPGRIP1L | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | NDUFS2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | PTPRG | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | NTMT1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | CLRN3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | LRCH3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | DPAGT1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | RPP30 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | HAGHL | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | VEGFC | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |